title: Rho GTPase-dependent signaling is required for macrophage migration inhibitory factor-mediated expression of cyclin D1.
abstract: Our previous studies demonstrated that the proinflammatory peptide, macrophage migration inhibitory factor (MIF), functions as an autocrine mediator of both growth factor- and integrin-dependent sustained ERK MAPK activation, cyclin D1 expression, and cell cycle progression. We now report that MIF promotes the activation of the canonical ERK MAPK cascade and cyclin D1 expression by stimulating the activity of the Rho GTPase and downstream signaling to stress fiber formation. Rho-dependent stress fiber accumulation promotes the sustained activation of ERK and subsequent cyclin D1 expression during G(1)-S phase cell cycle progression. This pathway is reported to be dependent upon myosin light chain (MLC) kinase, integrin clustering, and subsequent activation of focal adhesion kinase, leading to sustained MAPK activity. Our studies reveal that recombinant MIF induces cyclin D1 expression in a Rho-, Rho kinase-, MLC kinase-, and ERK-dependent manner in asynchronous NIH 3T3 fibroblasts. Moreover, MIF(-/-) murine embryonic fibroblasts display aberrant cyclin D1 expression that is linked to defective Rho activity, stress fiber formation, and MLC phosphorylation. These results suggest that MIF is an integral autocrine mediator of Rho GTPase-dependent signaling events and provide mechanistic insight into how MIF regulates proliferative, migratory, and oncogenic processes.
authors.affiliation: Department of Biochemistry and Molecular Biology, University of Louisville, KY 40202, USA.
authors.forename: James D
authors.initials: JD
authors.lastname: Swant
authors.forename: Beatriz E
authors.initials: BE
authors.lastname: Rendon
authors.forename: Marc
authors.initials: M
authors.lastname: Symons
authors.forename: Robert A
authors.initials: RA
authors.lastname: Mitchell
mesh_terms: D000818:Animals; D002465:Cell Movement; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic; D019938:Cyclin D1 / Q000096:biosynthesis / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation; D005347:Fibroblasts / Q000378:metabolism; D005982:Glutathione Transferase / Q000378:metabolism; D015151:Immunoblotting; D008156:Luciferases / Q000378:metabolism; D020935:MAP Kinase Signaling System; D008263:Macrophage Migration-Inhibitory Factors / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008856:Microscopy, Fluorescence; D008954:Models, Biological; D009219:Myosin-Light-Chain Kinase / Q000378:metabolism; D041681:NIH 3T3 Cells; D010766:Phosphorylation; D010957:Plasmids / Q000378:metabolism; D012190:Retroviridae / Q000235:genetics; D015398:Signal Transduction; D013997:Time Factors; D020741:rho GTP-Binding Proteins / Q000378:metabolism*
chemical_list: D008263:Macrophage Migration-Inhibitory Factors; D019938:Cyclin D1; D008156:Luciferases; D005982:Glutathione Transferase; D009219:Myosin-Light-Chain Kinase; D020741:rho GTP-Binding Proteins